Table 3.

Mean percent change from lead-in study baseline at 6-mo intervals for PTH, Ca×P, Ca, and P levels

Week	PTH		Ca × P		Ca		P
	Original cinacalcet mean (SE) [n]	Original placebo mean (SE) [n]	Original cinacalcet mean (SE) [n]	Original placebo mean (SE) [n]	Original cinacalcet mean (SE) [n]	Original placebo mean (SE) [n]	Original cinacalcet mean (SE) [n]	Original placebo mean (SE) [n]
Week 26	−51.2 (2.1) [318]	9.9 (2.8) [246]	−14.3 (1.7) [311]	2.1 (1.8) [242]	−5.9 (0.6) [316]	1.3 (0.4) [246]	−9.0 (1.7) [312]	1.0 (1.8) [242]
Week 54	−38.2 (2.9) [279]	−12.3 (4.8) [200]	−10.1 (2.0) [273]	−10.3 (2.2) [196]	−4.6 (0.6) [275]	−5.5 (0.8) [201]	−6.1 (1.8) [274]	−5.0 (2.1) [197]
Week 84	−28.8 (4.6) [222]	−25.5 (5.2) [155]	−11.1 (2.5) [221]	−12.3 (2.5) [153]	−6.1 (0.8) [225]	−5.2 (0.8) [159]	−6.0 (2.2) [221]	−7.9 (2.3) [153]
Week 108	−32.7 (4.4) [177]	−25.8 (6.5) [123]	−12.3 (2.2) [179]	−13.0 (2.6) [124]	−6.0 (0.9) [185]	−3.7 (0.8) [131]	−6.7 (2.1) [179]	−10.4 (2.5) [124]
Week 132	−35.0 (5.7) [110]	−38.4 (5.7) [83]	−7.7 (3.2) [112]	−20.1 (2.9) [82]	−5.3 (1.0) [116]	−4.0 (1.2) [84]	−4.1 (3.0) [113]	−16.0 (3.0) [83]
Week 156	−32.8 (9.0) [50]	−24.0 (11.3) [29]	−12.2 (4.7) [54]	−14.6 (4.4) [34]	−5.9 (1.3) [56]	−4.0 (1.7) [35]	−7.7 (4.5) [54]	−9.8 (5.2) [34]
Week 180	−49.7 (38.8) [2]	−55.9 (35.3) [2]	−9.6 (9.5) [9]	−17.8 (10.9) [8]	−5.7 (3.5) [10]	0.4 (2.9) [8]	−1.2 (13.5) [9]	−19.7 (10.7) [9]